Priscila Melo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Priscila Melo has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
- Ana Marina Ferreira
School of Engineering Newcastle University Newcastle upon Tyne UK
4 shared publications - Charalampos Tzivelekis
HMS Ltd, 8 Scafell Drive, Newcastle Upon Tyne, NE5 3XA, UK
2 shared publications - Chiara Vitale-Brovarone
Department of Applied Science and Technology (DISAT), Politecnico di Torino, Corso Duca degli Abruzzi 24, 10129 Torino, Italy
2 shared publications Connor Richardson
School of Engineering, Newcastle University, Newcastle upon Tyne, NE1 7RU, UK
2 shared publicationsDominika Zabiegaj
Department of Mechanical and Construction Engineering, Northumbria University, Newcastle upon Tyne, NE1 8ST, UK
2 shared publicationsFatma Ozdemir Steedman
School of Engineering, Newcastle University, Newcastle upon Tyne, NE1 7RU, UK
2 shared publications
Latest Publications
- Open Access
- 6 August 2026
- Published by Wiley in Advanced Therapeutics
- Vol. 9 (8) , e70164
Challenging the Status Quo: Standardisation, Regulation and the Rise of 3D In Vitro Models for a More Humane and Predictive Future in Healthcare
For decades, biomedical research has relied on two‐dimensional (2D) cell cultures and animal models to study human biology and develop new therapeutics. While these systems have been instrumental in advancing science, their limitations in capturing the complexity and variability of human physiology are increasingly evident. As therapeutic strategies become more sophisticated and personalised, the need for more predictive and human‐relevant models is becoming critical. In this Perspective, it is argued that three‐dimensional (3D) in vitro models such as organoids, bioprinted tissues, and microphysiological systems offer a necessary shift in how we approach disease modelling and drug development. These systems more accurately replicate tissue architecture, cellular interactions, and dynamic environments, yielding more meaningful insights into human biology. At the same time, they support a transition toward more ethical research practices by reducing reliance on animal testing. Discussing the scientific advances enabling these models, the growing regulatory and policy support for their adoption, and the key challenges that remain, is paramount. Addressing these barriers will require coordinated efforts across disciplines and sectors. The delayed adoption of these systems is also shaped by cultural inertia within the scientific and industrial ecosystems, where established methodologies still dominate due to familiarity, infrastructure and insufficient training.
- 6 August 2026
- Published by Wiley in Advanced Therapeutics
- Vol. 9 (8) , e70164
Open AccessChallenging the Status Quo: Standardisation, Regulation and the Rise of 3D In Vitro Models for a More Humane and Predictive Future in Healthcare
For decades, biomedical research has relied on two‐dimensional (2D) cell cultures and animal models to study human biology and develop new therapeutics. While these systems have been instrumental in advancing science, their limitations in capturing the complexity and variability of human physiology are increasingly evident. As therapeutic strategies become more sophisticated and personalised, the need for more predictive and human‐relevant models is becoming critical. In this Perspective, it is argued that three‐dimensional (3D) in vitro models such as organoids, bioprinted tissues, and microphysiological systems offer a necessary shift in how we approach disease modelling and drug development. These systems more accurately replicate tissue architecture, cellular interactions, and dynamic environments, yielding more meaningful insights into human biology. At the same time, they support a transition toward more ethical research practices by reducing reliance on animal testing. Discussing the scientific advances enabling these models, the growing regulatory and policy support for their adoption, and the key challenges that remain, is paramount. Addressing these barriers will require coordinated efforts across disciplines and sectors. The delayed adoption of these systems is also shaped by cultural inertia within the scientific and industrial ecosystems, where established methodologies still dominate due to familiarity, infrastructure and insufficient training.
- Open Access
- 27 May 2026
- Published by Elsevier in Journal of the Mechanical Behavior of Biomedical Materials
- Vol. 180, 107471
Effect of bio-ink physical properties on droplet volume in the reactive jet impingement 3D bioprinting system
- 27 May 2026
- Published by Elsevier in Journal of the Mechanical Behavior of Biomedical Materials
- Vol. 180, 107471
Open AccessEffect of bio-ink physical properties on droplet volume in the reactive jet impingement 3D bioprinting system
- Open Access
- 7 April 2026
- Published by Elsevier in SSRN Electronic Journal
Effect of bio-ink mechanical properties on droplet volume in the reactive jet impingement 3D bioprinting system
Reactive jet impingement is a 3D bioprinting process which forms cell filled hydrogels through reacting droplets of polymer and crosslinker solutions. This study evaluates for the first time the relationship between the droplet volumes of the hydrogels with the viscosity and surface tension of the starting solutions. Calcium chloride, sodium alginate, thrombin, and fibrinogen solutions are characterised together with two blended solutions: collagen-alginate-fibrin and thrombin-calcium chloride, which combine to create a collagen-alginate-fibrin hydrogel. The influence of cells on bio-ink behaviour has been assessed through suspending TC28a chondrocytes within the thrombin-calcium chloride solution. Viscosity was a greater differentiator in defining print volumes than surface tension, and there is a clear relationship between droplet volume and kinematic viscosity measured at high strain rates (1000 s-1). The addition of cells had a minimal effect on the kinematic viscosity of solutions at high strain rates and, therefore, on processing of cell filled hydrogels, meaning that processing high cell densities is possible without significant adjustments to processing parameters. Reactive jet impingement is a reliable and accurate process for creating high cell density hydrogels, and the kinematic viscosity at high strain rates is the key mechanical property in defining the relative print volumes of different inks.
- 7 April 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessEffect of bio-ink mechanical properties on droplet volume in the reactive jet impingement 3D bioprinting system
Reactive jet impingement is a 3D bioprinting process which forms cell filled hydrogels through reacting droplets of polymer and crosslinker solutions. This study evaluates for the first time the relationship between the droplet volumes of the hydrogels with the viscosity and surface tension of the starting solutions. Calcium chloride, sodium alginate, thrombin, and fibrinogen solutions are characterised together with two blended solutions: collagen-alginate-fibrin and thrombin-calcium chloride, which combine to create a collagen-alginate-fibrin hydrogel. The influence of cells on bio-ink behaviour has been assessed through suspending TC28a chondrocytes within the thrombin-calcium chloride solution. Viscosity was a greater differentiator in defining print volumes than surface tension, and there is a clear relationship between droplet volume and kinematic viscosity measured at high strain rates (1000 s-1). The addition of cells had a minimal effect on the kinematic viscosity of solutions at high strain rates and, therefore, on processing of cell filled hydrogels, meaning that processing high cell densities is possible without significant adjustments to processing parameters. Reactive jet impingement is a reliable and accurate process for creating high cell density hydrogels, and the kinematic viscosity at high strain rates is the key mechanical property in defining the relative print volumes of different inks.
- Open Access
- 26 April 2025
- Published by Wiley in Advanced NanoBiomed Research
- Vol. 5 (7)
Functional Synovium‐Based 3D Models in the Context of Human Disease and Inflammation
The synovium plays a crucial role in joint function and is a primary site of pathology in inflammatory joint diseases, such as rheumatoid arthritis (RA). Immune‐mediated inflammatory diseases (IMIDs), including RA, are becoming increasingly prevalent worldwide. However, the development of effective treatments remains hindered by the limitations of preclinical modeling techniques. Traditional methods, such as 2D in vitro monolayer cultures and animal models, often fail to replicate the complexity of human tissues. To address these challenges, tissue engineering (TE) and biofabrication strategies have emerged as promising alternatives. These approaches enable the creation of 3D in vitro models that better mimic physiological conditions. Techniques like 3D bioprinting allow researchers to replicate cellular interactions and the extracellular matrix, improving the accuracy of disease models. The application of 3D models in therapy development, drug screening, and personalized medicine has grown significantly. These platforms offer valuable insights into IMID pathophysiology by simulating relevant microenvironments. This review examines current synovium models used in IMID research and explores future directions in TE and 3D biofabrication. Additionally, the impact of inflammation on tissues and discuss the clinical potential of 3D disease models to address current disregarded aspects of coexistent diseases is highlighted.
- 26 April 2025
- Published by Wiley in Advanced NanoBiomed Research
- Vol. 5 (7)
Open AccessFunctional Synovium‐Based 3D Models in the Context of Human Disease and Inflammation
The synovium plays a crucial role in joint function and is a primary site of pathology in inflammatory joint diseases, such as rheumatoid arthritis (RA). Immune‐mediated inflammatory diseases (IMIDs), including RA, are becoming increasingly prevalent worldwide. However, the development of effective treatments remains hindered by the limitations of preclinical modeling techniques. Traditional methods, such as 2D in vitro monolayer cultures and animal models, often fail to replicate the complexity of human tissues. To address these challenges, tissue engineering (TE) and biofabrication strategies have emerged as promising alternatives. These approaches enable the creation of 3D in vitro models that better mimic physiological conditions. Techniques like 3D bioprinting allow researchers to replicate cellular interactions and the extracellular matrix, improving the accuracy of disease models. The application of 3D models in therapy development, drug screening, and personalized medicine has grown significantly. These platforms offer valuable insights into IMID pathophysiology by simulating relevant microenvironments. This review examines current synovium models used in IMID research and explores future directions in TE and 3D biofabrication. Additionally, the impact of inflammation on tissues and discuss the clinical potential of 3D disease models to address current disregarded aspects of coexistent diseases is highlighted.
- Open Access
Assessment of Collagen-Based Nanostructured Biomimetic Systems with a Co-Culture of Human Bone-Derived Cells
Osteoporosis is a worldwide disease resulting in the increase of bone fragility and enhanced fracture risk in adults. In the context of osteoporotic fractures, bone tissue engineering (BTE), i.e., the use of bone substitutes combining biomaterials, cells, and other factors, is considered a potential alternative to conventional treatments. Innovative scaffolds need to be tested in in vitro systems where the simultaneous presence of osteoblasts (OBs) and osteoclasts (OCs), the two main players of bone remodeling, is required to mimic their crosstalk and molecular cooperation. To this aim, two composite materials were developed, based on type I collagen, and containing either strontium-enriched mesoporous bioactive glasses or rod-like hydroxyapatite nanoparticles. The developed nanostructured systems underwent genipin chemical crosslinking and were then tested with an indirect co-culture of human trabecular bone-derived OBs and buffy coat-derived OC precursors, for 2–3 weeks. The favorable structural and biological properties of the materials proved to successfully support the viability, adhesion, and differentiation of cells, encouraging a further investigation of the developed bioactive systems as biomaterial inks for the 3D printing of more complex scaffolds for BTE.
Open AccessAssessment of Collagen-Based Nanostructured Biomimetic Systems with a Co-Culture of Human Bone-Derived Cells
Osteoporosis is a worldwide disease resulting in the increase of bone fragility and enhanced fracture risk in adults. In the context of osteoporotic fractures, bone tissue engineering (BTE), i.e., the use of bone substitutes combining biomaterials, cells, and other factors, is considered a potential alternative to conventional treatments. Innovative scaffolds need to be tested in in vitro systems where the simultaneous presence of osteoblasts (OBs) and osteoclasts (OCs), the two main players of bone remodeling, is required to mimic their crosstalk and molecular cooperation. To this aim, two composite materials were developed, based on type I collagen, and containing either strontium-enriched mesoporous bioactive glasses or rod-like hydroxyapatite nanoparticles. The developed nanostructured systems underwent genipin chemical crosslinking and were then tested with an indirect co-culture of human trabecular bone-derived OBs and buffy coat-derived OC precursors, for 2–3 weeks. The favorable structural and biological properties of the materials proved to successfully support the viability, adhesion, and differentiation of cells, encouraging a further investigation of the developed bioactive systems as biomaterial inks for the 3D printing of more complex scaffolds for BTE.
- Open Access
3D Printing in Alginic Acid Bath of In-Situ Crosslinked Collagen Composite Scaffolds
Bone-tissue regeneration is a growing field, where nanostructured-bioactive materials are designed to replicate the natural properties of the target tissue, and then are processed with technologies such as 3D printing, into constructs that mimic its natural architecture. Type I bovine collagen formulations, containing functional nanoparticles (enriched with therapeutic ions or biomolecules) or nanohydroxyapatite, are considered highly promising, and can be printed using support baths. These baths ensure an accurate deposition of the material, nonetheless their full removal post-printing can be difficult, in addition to undesired reactions with the crosslinking agents often used to improve the final structural integrity of the scaffolds. Such issues lead to partial collapse of the printed constructs and loss of geometrical definition. To overcome these limitations, this work presents a new alternative approach, which consists of adding a suitable concentration of crosslinking agent to the printing formulations to promote the in-situ crosslinking of the constructs prior to the removal of the support bath. To this aim, genipin, chosen as crosslinking agent, was added (0.1 wt.%) to collagen-based biomaterial inks (containing either 38 wt.% mesoporous bioactive glasses or 65 wt.% nanohydroxyapatite), to trigger the crosslinking of collagen and improve the stability of the 3D printed scaffolds in the post-processing step. Moreover, to support the material deposition, a 15 wt.% alginic acid solution was used as a bath, which proved to sustain the printed structures and was also easily removable, allowing for the stable processing of high-resolution geometries.
Open Access3D Printing in Alginic Acid Bath of In-Situ Crosslinked Collagen Composite Scaffolds
Bone-tissue regeneration is a growing field, where nanostructured-bioactive materials are designed to replicate the natural properties of the target tissue, and then are processed with technologies such as 3D printing, into constructs that mimic its natural architecture. Type I bovine collagen formulations, containing functional nanoparticles (enriched with therapeutic ions or biomolecules) or nanohydroxyapatite, are considered highly promising, and can be printed using support baths. These baths ensure an accurate deposition of the material, nonetheless their full removal post-printing can be difficult, in addition to undesired reactions with the crosslinking agents often used to improve the final structural integrity of the scaffolds. Such issues lead to partial collapse of the printed constructs and loss of geometrical definition. To overcome these limitations, this work presents a new alternative approach, which consists of adding a suitable concentration of crosslinking agent to the printing formulations to promote the in-situ crosslinking of the constructs prior to the removal of the support bath. To this aim, genipin, chosen as crosslinking agent, was added (0.1 wt.%) to collagen-based biomaterial inks (containing either 38 wt.% mesoporous bioactive glasses or 65 wt.% nanohydroxyapatite), to trigger the crosslinking of collagen and improve the stability of the 3D printed scaffolds in the post-processing step. Moreover, to support the material deposition, a 15 wt.% alginic acid solution was used as a bath, which proved to sustain the printed structures and was also easily removable, allowing for the stable processing of high-resolution geometries.
- 1 December 2020
- Published by Elsevier in Journal of the European Ceramic Society
- Vol. 40 (15) , 6107-6113
Effects of alumina on the thermal processing of apatite-wollastonite: Changes in sintering, microstructure and crystallinity of compressed pellets
- 1 December 2020
- Published by Elsevier in Journal of the European Ceramic Society
- Vol. 40 (15) , 6107-6113
Effects of alumina on the thermal processing of apatite-wollastonite: Changes in sintering, microstructure and crystallinity of compressed pellets
- 1 November 2019
- Published by Elsevier in Composites Science and Technology
- Vol. 184
Osteoinduction of 3D printed particulate and short-fibre reinforced composites produced using PLLA and apatite-wollastonite
- 1 November 2019
- Published by Elsevier in Composites Science and Technology
- Vol. 184
Osteoinduction of 3D printed particulate and short-fibre reinforced composites produced using PLLA and apatite-wollastonite